1 million adult vapers in England have never regularly smoked

Researchers estimate trends in vaping among adults in the United Kingdom who have not smoked regularly.

Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 18.09.2024 /

September 19, 2024

Pharmacists Improve Diabetes Control for Hispanic Patients

An intervention in which trained pharmacists assessed patients and made medication-adjustment recommendations to primary care physicians was associated with improved glycemic control in Hispanic patients

October 3, 2023

Why Healthcare AI Must Maintain Multiple Layers of Specificity

Dr. Tamir Wolf, co-founder and CEO of Theator The recent explosion of generative AI has pushed public discourse to a palpable tipping point. Nearly overnight,

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.